Amanote Research
Register
Sign In
Giving RSV Vaccine Intranasally.
BMJ
doi 10.1136/bmj.2.6201.1368
Full Text
Open PDF
Abstract
Available in
full text
Date
November 24, 1979
Authors
J McCormack
Publisher
BMJ
Related search
Protection of Calves by a Prefusion-Stabilized Bovine RSV F Vaccine
npj Vaccines
Infectious Diseases
Immunology
Pharmacology
New Insights for Development of a Safe and Protective RSV Vaccine
Human Vaccines
Recombinant Influenza Virus Expressing a Fusion Protein Neutralizing Epitope of Respiratory Syncytial Virus (RSV) Confers Protection Without Vaccine-Enhanced RSV Disease
Antiviral Research
Virology
Pharmacology
Immunogenicity and Efficacy of Recombinant RSV-F Vaccine in a Mouse Model
Vaccine
Molecular Medicine
Public Health
Veterinary
Microbiology
Environmental
Immunology
Infectious Diseases
Occupational Health
A Highly Stable Prefusion RSV F Vaccine Derived From Structural Analysis of the Fusion Mechanism
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
the Genetic Stability of PIV5-vectored RSV Vaccine Candidates After in Vitro and in Vivo Passage
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Comparison of Histochemical Methods for Murine Eosinophil Detection in an RSV Vaccine-Enhanced Inflammation Model
Toxicologic Pathology
Forensic Medicine
Toxicology
Pathology
Cell Biology
Molecular Biology
RSV Vaccine-Enhanced Disease Is Orchestrated by the Combined Actions of Distinct CD4 T Cell Subsets
PLoS Pathogens
Immunology
Molecular Biology
Virology
Microbiology
Parasitology
Genetics
Development of a Virosomal RSV Vaccine Containing 3d-Phad® Adjuvant: Formulation, Composition, and Long-Term Stability
Pharmaceutical Research
Organic Chemistry
Biotechnology
Molecular Medicine
Pharmacology
Pharmaceutical Science